J. Attems

J. Attems, U. Pötschger, W. Köstler, 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Exome sequencing in dementia with Lewy bodies

J. O'Brien, J. Attems, C. Morris, 2016, Translational Psychiatry.

Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates

J. Attems, J. Hedreen, D. Mann, 2020, Acta Neuropathologica.

Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders

I. McKeith, D. Erskine, J. Attems, 2021, Acta Neuropathologica.

RAB39B is redistributed in dementia with Lewy bodies and is sequestered within aβ plaques and Lewy bodies

J. Attems, F. Giorgini, T. Outeiro, 2020, Brain pathology.

The relationship between subcortical tau pathology and Alzheimer's disease.

K. Jellinger, J. Attems, D. Thal, 2012, Biochemical Society transactions.

Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS

E. Haan, P. Pietrini, R. Petersen, 2017, Scientific Reports.

D. Hernandez, M. Nalls, L. Ferrucci, 2017, bioRxiv.

Post-mortem assessment in vascular dementia: advances and aspirations

K. Jellinger, T. Hortobágyi, J. Attems, 2016, BMC Medicine.

Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue.

K. Jellinger, J. Attems, D. Mann, 2014, American journal of neurodegenerative disease.

Frontotemporal dementia and its subtypes: a genome-wide association study

Alexander Gerhard, Adrian Danek, Luigi Ferrucci, 2014, The Lancet Neurology.

Olfaction and Aging: A Mini-Review

K. Jellinger, J. Attems, L. Walker, 2015, Gerontology.

Neuropathological approaches to cerebral aging and neuroplasticity

K. Jellinger, J. Attems, 2013, Dialogues in clinical neuroscience.

Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.

K. Jellinger, J. Attems, K A Jellinger, 2006, Clinical neuropathology.

High‐level ERBB2 gene amplification is associated with a particularly short time‐to‐metastasis, but results in a high rate of complete response once trastuzumab‐based therapy is offered in the metastatic setting

J. Attems, E. Kubista, C. Singer, 2014, International journal of cancer.

Is the time ripe for new diagnostic criteria of cognitive impairment due to cerebrovascular disease? Consensus report of the International Congress on Vascular Dementia working group

J. Attems, M. Sarazin, R. Perneczky, 2016, BMC Medicine.

Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer’s disease

A. Hoischen, J. Attems, J. Veltman, 2018, Alzheimer's & Dementia.

Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains

J. Attems, C. Morris, C. Troakes, 2017, Acta neuropathologica communications.

Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy

J. Attems, R. Carare, R. Kalaria, 2016, Neuropathology and applied neurobiology.

CD8+ T-cells infiltrate Alzheimer’s disease brains and regulate neuronal- and synapse-related gene expression in APP-PS1 transgenic mice

J. Attems, M. Heneka, L. Aigner, 2020, Brain, Behavior, and Immunity.

Impairments to the lateral geniculate nucleus in Alzheimer ’ s disease but not dementia with Lewy bodies

I. McKeith, A. Khundakar, D. Erskine, 2018 .

Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies

Alan J. Thomas, I. McKeith, A. Khundakar, 2015, Neuropathology and applied neurobiology.

Common Impact of Chronic Kidney Disease and Brain Microhemorrhages on Cerebral Aβ Pathology in SHRSP

J. Attems, H. Heinze, D. Pirici, 2017, Brain pathology.

Neurodegenerative Diseases and Ageing.

D. Erskine, J. Attems, K. E. McAleese, 2019, Sub-cellular biochemistry.

Neurochemical mapping of the human hippocampus reveals perisynaptic matrix around functional synapses in Alzheimer’s disease

H. Tanila, A. Alpár, T. Harkany, 2013, Acta Neuropathologica.

Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies.

J. Attems, I. Zerr, S. Rizzoli, 2019, Cell reports.

Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias.

J. O'Brien, J. Attems, S. Colloby, 2012, Brain : a journal of neurology.

Alzheimer's disease pathology in synucleinopathies

J. Attems, 2017, The Lancet Neurology.

Aging 6-2019 Limbic-Predominant Age-Related TDP-43 Encephalopathy ( LATE ) : Consensus Working Group Report

C. Jack, T. Montine, J. Trojanowski, 2019 .

SIRT1, miR-132 and miR-212 link human longevity to Alzheimer’s Disease

J. Attems, D. Gurwitz, M. Puzianowska-Kuźnicka, 2018, Scientific Reports.

Pathology of clinical and preclinical Alzheimer’s disease

J. Attems, R. Mrak, C. V. von Arnim, 2013, European Archives of Psychiatry and Clinical Neuroscience.

Challenges of multimorbidity of the aging brain: a critical update

K. Jellinger, J. Attems, 2015, Journal of Neural Transmission.

Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer’s disease

Alan J. Thomas, P. Hanson, J. Attems, 2014, Acta Neuropathologica.

Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology

K. Jellinger, J. Attems, F. Lintner, 2007, Journal of the Neurological Sciences.

Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease

K. Jellinger, J. Attems, 2005, Journal of the Neurological Sciences.

Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology—a pilot study

K. Jellinger, J. Attems, 2004, Acta Neuropathologica.

Correlation of pyroglutamate amyloid β and ptau Ser202/Thr205 levels in Alzheimer’s disease and related murine models

J. Attems, B. Hutter-Paier, L. Walker, 2020, PloS one.

Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia

T. Hortobágyi, J. Attems, D. Aarsland, 2016, Alzheimer's & Dementia.

Unfolded protein response is activated in Lewy body dementias

T. Hortobágyi, J. Attems, D. Aarsland, 2016, Neuropathology and applied neurobiology.

Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB

Alan J. Thomas, I. McKeith, J. O'Brien, 2017, Neurology.

Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease

K. Jellinger, J. Attems, 2008, Acta Neuropathologica.

Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease

K. Jellinger, J. Attems, K. A. Jellinger, 2007, Acta Neuropathologica.

Tau and α-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs

K. Jellinger, J. Attems, Magdalena Quass, 2006, Acta Neuropathologica.

Neuropathology and biochemistry of early onset familial Alzheimer’s disease caused by presenilin-1 missense mutation Thr116Asn

J. Attems, P. Turčáni, N. Zilka, 2018, Journal of Neural Transmission.

The renaissance of Ca2+-binding proteins in the nervous system: secretagogin takes center stage.

T. Hökfelt, J. Mulder, A. Alpár, 2012, Cellular signalling.

Doublecortin expression in CD8+ T-cells and microglia at sites of amyloid-β plaques: A potential role in shaping plaque pathology?

A. Khundakar, J. Attems, E. Masliah, 2018, Alzheimer's & Dementia.

Alzheimer’s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy

K. Jellinger, J. Attems, F. Lintner, 2005, Acta Neuropathologica.

Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy

K. Jellinger, J. Attems, F. Lauda, 2008, Journal of Neurology.

Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms

J. Attems, 2005, Acta Neuropathologica.

Neuropathological evaluation of mixed dementia

K. Jellinger, J. Attems, K. Jellinger, 2007, Journal of the Neurological Sciences.

Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism

K. Jellinger, J. Attems, J. Attems, 2006, Acta neurologica Scandinavica.

Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study

K. Jellinger, J. Attems, 2002, Acta Neuropathologica.

Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment.

T. Hortobágyi, J. Attems, D. Mann, 2016, Brain : a journal of neurology.

Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia

Alan J. Thomas, T. Hortobágyi, J. O'Brien, 2014, F1000Research.

Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatment

J. Attems, E. Kubista, C. Singer, 2003, British Journal of Cancer.

Quantitative neuropathological assessment to investigate cerebral multi-morbidity

Janna H. Neltner, J. Attems, P. Nelson, 2014, Alzheimer's Research & Therapy.

Edinburgh Research Explorer Deposition of amyloid in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy

J. Attems, R. Carare, Colin Smith, 2015 .

Genetic risk for Alzheimer’s disease influences neuropathology via multiple biological pathways

J. Attems, N. Cairns, J. Mill, 2020, medRxiv.

Cytosolic Trapping of a Mi tochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies Graphical

J. Attems, I. Zerr, S. Rizzoli, 2019 .

Frontal white matter lesions in Alzheimer’s disease are associated with both small vessel disease and AD-associated cortical pathology

Alan J. Thomas, J. Attems, S. Colloby, 2021, Acta Neuropathologica.

α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity

I. McKeith, D. Erskine, J. Attems, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study

K. Jellinger, T. Hortobágyi, J. Trojanowski, 2021, Acta Neuropathologica.

Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer’s disease

Alan J. Thomas, S. Reeves, J. Attems, 2020, Brain : a journal of neurology.

Concomitant LATE‐NC in Alzheimer's disease is not associated with increased tau or amyloid‐β pathological burden

Alan J. Thomas, D. Erskine, J. Attems, 2020, Neuropathology and applied neurobiology.

Prevalence and Pathology of Dementia with Lewy Bodies in the Oldest Old: A Comparison with Other Dementing Disorders

K. Jellinger, J. Attems, 2011, Dementia and Geriatric Cognitive Disorders.

Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia

Alan J. Thomas, J. Attems, S. Colloby, 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Amyloid β peptide 1–42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology

K. Jellinger, J. Attems, F. Lintner, 2004, Acta Neuropathologica.

A platelet protein biochip rapidly detects an Alzheimer’s disease-specific phenotype

Christopher Gerner, J. Attems, R. Baumgartner, 2014, Acta Neuropathologica.

Dynamin 1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia

Alan J. Thomas, T. Hortobágyi, J. O'Brien, 2015 .

Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy.

M. Mesulam, P. Hof, J. Trojanowski, 2020, Journal of neuropathology and experimental neurology.

PART, a distinct tauopathy, different from classical sporadic Alzheimer disease

K. Jellinger, C. Jack, T. Montine, 2015, Acta Neuropathologica.

Comparative anatomical distribution of neuronal calcium-binding protein (NECAB) 1 and -2 in rodent and human spinal cord

T. Hökfelt, Masahiko Watanabe, J. Mulder, 2016, Brain structure & function.

Correlations between cortical and subcortical tau pathology

K. Jellinger, J. Attems, A. Thomas, 2012, Neuropathology and applied neurobiology.

Reduced secretagogin expression in the hippocampus of P301L tau transgenic mice

K. Jellinger, J. Attems, R. Nitsch, 2011, Journal of Neural Transmission.

Calcium‐binding protein secretagogin‐expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease

K. Jellinger, J. Attems, M. Preusser, 2007, Neuropathology and applied neurobiology.

Pseudomesotheliomatous adenocarcinoma of the lung with rhabdoid features.

J. Attems, F. Lintner, 2001, Pathology, research and practice.

J. Attems, F. Lintner, R. Rumetshofer, 2007, Wiener klinische Wochenschrift.

Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients.

K. Jellinger, J. Attems, P. Bugert, 2012, Journal of proteomics.

Dementia in Parkinson's disease is associated with enhanced mitochondrial complex I deficiency

J. Attems, P. Francis, J. Bateman, 2016, Movement disorders : official journal of the Movement Disorder Society.

Extended post-mortem delay times should not be viewed as a deterrent to the scientific investigation of human brain tissue: a study from the Brains for Dementia Research Network Neuropathology Study Group, UK

D. Lett, J. Attems, D. Mann, 2016, Acta Neuropathologica.

Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia.

Nick C Fox, Alan J. Thomas, D. Hernandez, 2018, Nature Medicine.

A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

Nick C Fox, Alan J. Thomas, D. Hernandez, 2018, Brain : a journal of neurology.

Expression of TAU in insulin-secreting cells and its interaction with the calcium-binding protein secretagogin.

J. Attems, D. Neziri, L. Wagner, 2010, The Journal of endocrinology.

Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia.

Alan J. Thomas, T. Hortobágyi, J. O'Brien, 2015, Journal of Alzheimer's disease : JAD.

Neurodegenerative brain changes are associated with area deprivation in the United Kingdom: findings from the Brains for Dementia Research study

Alan J. Thomas, D. Erskine, J. Attems, 2021, Acta neuropathologica communications.

Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies – current issues and future directions

J. Attems, L. Stefanis, L. Walker, 2019, Journal of neurochemistry.

Neuropathological Changes in Dementia With Lewy Bodies and the Cingulate Island Sign

Alan J. Thomas, J. Attems, C. Morris, 2019, Journal of neuropathology and experimental neurology.

Amyloid and tau: neither chicken nor egg but two partners in crime!

K. Jellinger, J. Attems, 2013, Acta Neuropathologica.

Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?

K. Jellinger, J. Attems, Kurt A. Jellinger, 2006, Acta Neuropathologica.

Neuronal Loss and Α-Synuclein Pathology in the Superior Colliculus and Its Relationship to Visual Hallucinations in Dementia with Lewy Bodies.

Alan J. Thomas, John-Paul Taylor, I. McKeith, 2017, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Creating the Pick’s disease International Consortium: Association study of MAPT H2 haplotype with risk of Pick’s disease

Derek H. Oakley, A. Singleton, D. Vitale, 2023, medRxiv.

Insights into Lewy body disease from rare neurometabolic disorders

D. Erskine, J. Attems, 2021, Journal of Neural Transmission.

Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias

T. Hortobágyi, J. O'Brien, J. Attems, 2014, Brain pathology.

The need to unify neuropathological assessments of vascular alterations in the ageing brain Multicentre survey by the BrainNet Europe consortium

K. Jellinger, T. Hortobágyi, J. Attems, 2012, Experimental Gerontology.

Pathological Changes to the Subcortical Visual System and its Relationship to Visual Hallucinations in Dementia with Lewy Bodies

Alan J. Thomas, I. McKeith, D. Collerton, 2019, Neuroscience Bulletin.

Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS

Nick C Fox, D. Hernandez, M. Nalls, 2017, Scientific Reports.

Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders

Alan J. Thomas, J. Attems, C. Morris, 2019, Brain pathology.

Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer's disease and vascular dementia.

J. Attems, R. Akinyemi, R. Kalaria, 2013, Current Alzheimer research.

Importance of Proactive Treatment of Depression in Lewy Body Dementias: The Impact on Hippocampal Neurogenesis and Cognition in a Post-Mortem Study

E. Perry, J. Attems, D. Aarsland, 2018, Dementia and Geriatric Cognitive Disorders.

Cerebral amyloid angiopathy in Lewy body disease

K. Jellinger, J. Attems, K. Jellinger, 2008, Journal of Neural Transmission.

Connectivity of the Subgenual Cingulate Region

J. Attems, F. Vergani, K. Ashkan, 2018 .

Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load

Alan J. Thomas, I. McKeith, D. Lett, 2015, Neurology.

The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies

J. Attems, E. Masliah, L. Aigner, 2020, Neurotherapeutics.

Protease-resistant SOD1 aggregates in amyotrophic lateral sclerosis demonstrated by paraffin-embedded tissue (PET) blot

J. Attems, A. Ludolph, D. Thal, 2014, Acta neuropathologica communications.

Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load.

J. Attems, D. Aarsland, C. Ballard, 2017, Journal of Alzheimer's disease : JAD.

Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies

I. McKeith, A. Khundakar, P. Hanson, 2018, Movement disorders : official journal of the Movement Disorder Society.

Improving the identification of dementia with Lewy bodies in the context of an Alzheimer’s-type dementia

Alan J. Thomas, D. Lett, John-Paul Taylor, 2018, Alzheimer's Research & Therapy.

Relationship Between Tau, β Amyloid and α-Synuclein Pathologies.

J. Attems, L. Walker, 2019, Advances in experimental medicine and biology.

Lung disease 35 years after aspiration of activated charcoal in combination with pulmonary lymphangioleiomyomatosis

J. Attems, G. Reinisch, F. Lintner, 2006, Virchows Archiv.

Defining the Riddle in Order to Solve It: There Is More Than One “Parkinson's Disease”

M. Chesselet, O. Rascol, I. McKeith, 2023, Movement disorders : official journal of the Movement Disorder Society.

Stage-Speci fi c Changes in Neurogenic and Glial Markers in Alzheimer ’ s Disease

E. Perry, J. Attems, C. Brayne, 2015 .

An isoform‐specific role of FynT tyrosine kinase in Alzheimer's disease

J. Attems, M. Tan, M. Lai, 2016, Journal of neurochemistry.

123I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson’s disease and Alzheimer’s disease: a new quantitative analysis of autopsy confirmed cases

J. Attems, D. Costa, Z. Walker, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE-ε4/TOMM40 long poly-T repeat allele variants

P. Muglia, J. Attems, I. Prokopenko, 2019, Alzheimer's & dementia.

Magnetic resonance imaging of fixed post mortem brains reliably reflects subcortical vascular pathology of frontal, parietal and occipital white matter

K. Jellinger, J. Attems, M. Esiri, 2013, Neuropathology and applied neurobiology.

Genome-wide association study of autopsy-confirmed Multiple System Atrophy identifies common variants near ZIC1 and ZIC4

Alan J. Thomas, A. Peters, G. Schellenberg, 2021, medRxiv.

Alzheimer Pathology in the olfactory bulb

K. Jellinger, J. Attems, 2005, Neuropathology and applied neurobiology.

Erratum to: Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains

J. Attems, C. Morris, C. Troakes, 2017, Acta neuropathologica communications.

Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies

D. Erskine, N. Lax, D. Turnbull, 2020, Acta Neuropathologica Communications.

Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs.

K. Jellinger, J. Attems, Magdalena Quass, 2007, Acta neuropathologica.

Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

Ryan L. Collins, Sonja W. Scholz, Toshiko Tanaka, 2023, Cell genomics.

Author response: Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB

Alan J. Thomas, I. McKeith, J. O'Brien, 2017, Neurology.

Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies

K. Jellinger, J. Attems, 2009 .

Neuropathology and general autopsy findings in nondemented aged subjects.

K. Jellinger, J. Attems, 2012, Clinical neuropathology.

Hypertension drives parenchymal β-amyloid accumulation in the brain parenchyma

R. Knight, J. Attems, H. Heinze, 2014, Annals of clinical and translational neurology.

Cerebral amyloid angiopathy distribution in older people: A cautionary note

J. Attems, P. Francis, A. Hainsworth, 2021, Alzheimer's & dementia.

Capillary CAA and perivascular Abeta-deposition

J. Attems, D. Thal, H. Yamaguchi, 2010 .

Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia

Alan J. Thomas, T. Hortobágyi, J. O'Brien, 2017, Journal of Alzheimer's disease : JAD.

Dopamine and vesicular monoamine transport loss supports incidental Lewy body disease as preclinical idiopathic Parkinson

J. Attems, L. Zecca, C. Pifl, 2023, NPJ Parkinson's disease.

Amyloid PET and MRI in Alzheimer's disease and mild cognitive impairment.

P Knoll, S Mirzaei, C Kuntner, 2009, Current Alzheimer research.

Vascular α1A Adrenergic Receptors as a Potential Therapeutic Target for IPAD in Alzheimer’s Disease

J. Attems, R. Carare, Colin Smith, 2020, Pharmaceuticals.

European Journal of Geriatrics

K. Jellinger, J. Attems, F. Lintner, 2006 .

CXCR4 involvement in neurodegenerative diseases

O. Andreassen, G. Schellenberg, A. Dale, 2017, bioRxiv.

Edinburgh Research Explorer Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains

J. Attems, C. Morris, C. Troakes, 2022 .

J. Attems, L. Walker, Calum A. Hamilton, 2023, Brain Pathology.

SIRT1, miR-132 and miR-212 link human longevity to Alzheimer’s Disease

J. Attems, D. Gurwitz, M. Puzianowska-Kuźnicka, 2018, Scientific Reports.

Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

P. Pietrini, R. Desikan, J. Trojanowski, 2019, Scientific Reports.

Immunoreactivity of calcium binding protein secretagogin in the human hippocampus is restricted to pyramidal neurons

K. Jellinger, J. Attems, S. Steurer, 2007, Experimental Gerontology.

Cortical tau pathology: a major player in fibre-specific white matter reductions in Alzheimer's disease?

Charles DeCarli, Alan J. Thomas, John-Paul Taylor, 2018, Brain : a journal of neurology.

Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource

J. Attems, C. Troakes, S. Rollinson, 2017, Genome research.

Reply to Mordant et al.

J. Attems, W. Köstler, S. Watzka, 2011 .

Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations

I. McKeith, A. Khundakar, P. Hanson, 2016, Acta Neuropathologica Communications.

K. Jellinger, T. Hortobágyi, T. Montine, 2015, Acta Neuropathologica.

Specific patterns of neuronal loss in the pulvinar nucleus in dementia with lewy bodies

I. McKeith, A. Khundakar, D. Erskine, 2017, Movement disorders : official journal of the Movement Disorder Society.

Is there pure vascular dementia in old age?

K. Jellinger, J. Attems, 2010, Journal of the Neurological Sciences.

The Role of Telomerase Protein TERT in Alzheimer's Disease and in Tau-Related Pathology In Vitro

J. Attems, G. Saretzki, S. Miwa, 2015, The Journal of Neuroscience.

The impact of concomitant LATE‐NC on hyperphosphorylated tau pathology and cognitive decline in Alzheimer’s disease

D. Erskine, J. Attems, Kirsty E. McAleese, 2020 .

The aetiology of frontal white matter lesions in Alzheimer’s disease are associated with both neurodegenerative and ischemic mechanisms

C. DeCarli, J. Attems, Sophie Graham, 2020 .

Additional file 8: Table S4. of Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations

Alan J. Thomas, I. McKeith, A. Khundakar, 2016 .

O2-01-04 Tau and alpha-synuclein brainstem pathology in Alzheimer disease

K. Jellinger, J. Attems, F. Lintner, 2006, Alzheimer's & Dementia.